These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 17207054

  • 1. Total steroid dose given to ventilated newborn infants with chronic lung disease.
    Jones BO, Davies MW.
    J Paediatr Child Health; 2007; 43(1-2):40-3. PubMed ID: 17207054
    [Abstract] [Full Text] [Related]

  • 2. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 3. Transient increase in intraocular pressure during a dose-tapering regime of systemic dexamethasone in preterm infants.
    Ng PC, Lee CH, Tam BS, Wong SP, Lam HS, Kwok AK, Fok TF.
    Ophthalmology; 2008 May; 115(5):e7-14. PubMed ID: 18321580
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
    Odd DE, Armstrong DL, Teele RL, Kuschel CA, Harding JE.
    J Paediatr Child Health; 2004 May; 40(5-6):282-9. PubMed ID: 15151582
    [Abstract] [Full Text] [Related]

  • 5. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M, El-Khoury N, Parton L, Ballabh P, LaGamma EF.
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [Abstract] [Full Text] [Related]

  • 6. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J, Beedgen B, Böhler T, Sontheimer D, Zilow EP, Linderkamp O.
    Klin Padiatr; 1996 Apr; 208(2):56-60. PubMed ID: 8901183
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ, Brans YW, Poland RL.
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [Abstract] [Full Text] [Related]

  • 8. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes.
    Peaceman AM, Bajaj K, Kumar P, Grobman WA.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1165-9. PubMed ID: 16157131
    [Abstract] [Full Text] [Related]

  • 9. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR.
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [Abstract] [Full Text] [Related]

  • 10. Effect of prolonged dexamethasone on oxygen-dependency in infants with chronic lung disease.
    Zanardo V, Trevisanuto D, Vanin E, Marzari F, Guglielmi A.
    Pediatr Med Chir; 1999 May; 21(1):1-4. PubMed ID: 10451887
    [Abstract] [Full Text] [Related]

  • 11. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.
    Ng PC, Lam CW, Lee CH, Chan IH, Wong SP, Fok TF.
    Neonatology; 2008 May; 94(3):170-5. PubMed ID: 18612214
    [Abstract] [Full Text] [Related]

  • 12. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA, Harrison M, Clark RH.
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [Abstract] [Full Text] [Related]

  • 13. Short-term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone.
    Bar-Lev MR, Maayan-Metzger A, Matok I, Heyman Z, Sivan E, Kuint J.
    Obstet Gynecol; 2004 Sep; 104(3):484-8. PubMed ID: 15339757
    [Abstract] [Full Text] [Related]

  • 14. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO, Anstead MI, Shook LA.
    Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598
    [Abstract] [Full Text] [Related]

  • 15. Antenatal steroid use is associated with increased gastroesophageal reflux in neonates.
    Chin SO, Brodsky NL, Bhandari V.
    Am J Perinatol; 2003 May 05; 20(4):205-13. PubMed ID: 12874732
    [Abstract] [Full Text] [Related]

  • 16. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL, Mettelman BB, Bode MM, Gross SJ.
    J Pediatr; 2019 Aug 05; 211():20-26.e1. PubMed ID: 31349916
    [Abstract] [Full Text] [Related]

  • 17. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM, Carbone J, Belden L, Borgida AF, Herson V.
    Am J Obstet Gynecol; 2007 Sep 05; 197(3):284.e1-4. PubMed ID: 17826422
    [Abstract] [Full Text] [Related]

  • 18. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
    Forest S.
    J Perinat Neonatal Nurs; 2011 Sep 05; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
    [Abstract] [Full Text] [Related]

  • 19. Growth in high risk infants <1500 g birthweight during the first 5 weeks.
    Loui A, Tsalikaki E, Maier K, Walch E, Kamarianakis Y, Obladen M.
    Early Hum Dev; 2008 Oct 05; 84(10):645-50. PubMed ID: 18539413
    [Abstract] [Full Text] [Related]

  • 20. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators.
    Pediatrics; 2007 Apr 05; 119(4):716-21. PubMed ID: 17403842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.